Literature DB >> 24216720

Baseline predictors of adherence to positive airway pressure therapy for sleep apnea: a 10-year single-center observational cohort study.

Otto D Schoch1, Florent Baty, Jolanda Niedermann, Jochen J Rüdiger, Martin H Brutsche.   

Abstract

BACKGROUND: Positive airway pressure (PAP) therapy is the standard treatment for obstructive sleep apnea syndrome (OSAS).
OBJECTIVES: The aim of the current study was to determine operational long-term adherence to PAP and its predictors.
METHODS: In a retrospective single-center observational cohort study, we analyzed all patients referred to our center with suspected OSAS between November 2001 and November 2011. Baseline results and last follow-up data of each patient were analyzed. Kaplan-Meier estimates of adherence and Cox proportional hazard regression for age, gender, Epworth sleepiness scale (ESS) scores, body mass index, apnea-hypopnea index (AHI) and oxygen desaturation index (ODI) were performed. Evolution of adherence was analyzed in yearly cohorts comparing the proportion of patients discontinuing PAP within 6 and 12 months.
RESULTS: Of 4,638 referrals, 2,187 confirmed OSAS patients started PAP, 297 (14%) were referred out to other centers to follow-up, 42 (2%) died, and 92 (5%) no longer needed PAP. Of 1,756 patients, the median follow-up was 36 months [95% confidence interval (CI) 33.6-37.8], and adherence at 1, 5 and 10 years was 74 (CI 71-75; n = 1,028), 55 (CI 53-58; n = 281) and 51% (CI 48-55; n = 10), respectively. Adherence is associated with ESS score [hazard ratio (HR) 0.60; CI 0.47-0.78], ODI (HR 0.50; CI 0.32-0.77) and AHI (HR 0.56; CI 0.37-0.85). In yearly cohorts according to inclusion date, the absconder rate at 6 and 12 months was 20 (CI 18-22) and 27% (CI 25-30) for the first 8 years and improved to 10 (CI 7-15) and 14% (CI 10-19) for the last 2 years, respectively.
CONCLUSIONS: Long-term adherence to PAP in OSAS is associated with baseline measures of disease severity. After 2009, an improvement in the adherence rate was observed.

Entities:  

Mesh:

Year:  2013        PMID: 24216720     DOI: 10.1159/000354186

Source DB:  PubMed          Journal:  Respiration        ISSN: 0025-7931            Impact factor:   3.580


  13 in total

1.  Untreated Sleep Apnea: An Analysis of Administrative Data to Identify Risk Factors for Early Nonadherence.

Authors:  Aliza Gordon; Sze-Jung Wu; Nicole Munns; Andrea DeVries; Thomas Power
Journal:  J Clin Sleep Med       Date:  2018-08-15       Impact factor: 4.062

2.  Insomnia complaints in lean patients with obstructive sleep apnea negatively affect positive airway pressure treatment adherence.

Authors:  Bjorg Eysteinsdottir; Thorarinn Gislason; Allan I Pack; Bryndís Benediktsdottir; Erna S Arnardottir; Samuel T Kuna; Erla Björnsdottir
Journal:  J Sleep Res       Date:  2016-12-15       Impact factor: 3.981

3.  CPAP Adherence Predictors in a Randomized Trial of Moderate-to-Severe OSA Enriched With Women and Minorities.

Authors:  Anna M May; Tarek Gharibeh; Lu Wang; Amanda Hurley; Harneet Walia; Kingman P Strohl; Reena Mehra
Journal:  Chest       Date:  2018-04-21       Impact factor: 9.410

4.  Hypoglossal nerve stimulation versus positive airway pressure therapy for obstructive sleep apnea.

Authors:  Clemens Heiser; Armin Steffen; Patrick J Strollo; Claire Giaie-Miniet; Olivier M Vanderveken; Benedikt Hofauer
Journal:  Sleep Breath       Date:  2022-07-02       Impact factor: 2.816

5.  Hypoglossal Nerve Stimulation for Obstructive Sleep Apnea in Spain: Implementation Strategy and Early Results in a Tertiary Care Center.

Authors:  Peter Michael Baptista; Carlos Prieto-Matos; Manuel Alegre-Esteban; Elena Urrestarazu-Bolumburu; Juan Alcade Navarrete
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2021-03-14

6.  Dose-response relationship between positive airway pressure therapy and excessive daytime sleepiness: the HomePAP study.

Authors:  Maeve Pascoe; James Bena; Noah D Andrews; Dennis Auckley; Ruth Benca; Martha E Billings; Vishesh K Kapur; Conrad Iber; Phyllis C Zee; Susan Redline; Carol L Rosen; Nancy Foldvary-Schaefer
Journal:  J Clin Sleep Med       Date:  2022-04-01       Impact factor: 4.324

Review 7.  A clinical approach to obstructive sleep apnea as a risk factor for cardiovascular disease.

Authors:  Micha T Maeder; Otto D Schoch; Hans Rickli
Journal:  Vasc Health Risk Manag       Date:  2016-03-21

8.  Impact of a New Nasal Pillows Mask on Patients' Acceptance, Compliance, and Willingness to Remain on CPAP Therapy.

Authors:  Alison Wimms; Sahisha Ketheeswaran; Claus Ziegenbein; Laura Jennings; Holger Woehrle
Journal:  Sleep Disord       Date:  2016-08-25

9.  Mandibular advancement device use in obstructive sleep apnea: ORCADES study 5-year follow-up data.

Authors:  Marie-Françoise Vecchierini; Valérie Attali; Jean-Marc Collet; Marie-Pia d'Ortho; Frederic Goutorbe; Jean-Baptiste Kerbrat; Damien Leger; Florent Lavergne; Christelle Monaca; Pierre-Jean Monteyrol; Eric Mullens; Bernard Pigearias; Francis Martin; Hauria Khemliche; Lionel Lerousseau; Jean-Claude Meurice
Journal:  J Clin Sleep Med       Date:  2021-08-01       Impact factor: 4.324

10.  Adaptive servo ventilation for central sleep apnoea in heart failure: SERVE-HF on-treatment analysis.

Authors:  Holger Woehrle; Martin R Cowie; Christine Eulenburg; Anna Suling; Christiane Angermann; Marie-Pia d'Ortho; Erland Erdmann; Patrick Levy; Anita K Simonds; Virend K Somers; Faiez Zannad; Helmut Teschler; Karl Wegscheider
Journal:  Eur Respir J       Date:  2017-08-31       Impact factor: 16.671

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.